Literature DB >> 32087328

TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.

Hua Luo1, Lu Yang2, Chen Liu3, Xiaobo Wang3, Qiang Dong2, Liangren Liu2, Qiang Wei4.   

Abstract

As reported in numerous studies, long non-coding RNAs (lncRNAs) exert significant effect on the regulation of tumor development. LncRNA TMPO antisense RNA 1 (TMPO-AS1) has been confirmed to be implicated in the development of several cancers. However, its clinical significance is still largely unknown in bladder cancer (BCa). In this study, high expression of TMPO-AS1 was revealed in BCa tissues and cell lines, and TMPO-AS1 predicted poor prognosis. Moreover, TMPO-AS1 facilitated cell growth. Additionally, TMPO-AS1 also boosted the migration and invasion of BCa cells. Mechanistically, overexpressed EBF transcription factor 1 (EBF1) in BCa cell was verified to promote the transcription of TMPO-AS1. Later, we found that TMPO-AS1 was a cytoplasmic RNA and could sponge miR-98-5p. Besides, it was validated that EBF1 is a target gene of miR-98-5p and negatively correlated with miR-98-5p in terms of expression level. According to the results of rescue experiments, we observed that EBF1 overexpression restored the repressive effect of TMPO-AS1 silencing on BCa development. Our research is the first to disclose the biological role and molecular mechanism of TMPO-AS1 in BCa, and TMPO-AS1 might be identified as a new therapeutic target for BCa patients.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bladder cancer; EBF1; TMPO-AS1; miR-98-5p

Year:  2020        PMID: 32087328     DOI: 10.1016/j.biocel.2020.105702

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer.

Authors:  Yangming Chen; Yujie Lei; Jianbin Lin; Yunchao Huang; Jiguang Zhang; Kai Chen; Shihui Sun; Xing Lin
Journal:  Onco Targets Ther       Date:  2020-10-20       Impact factor: 4.147

2.  Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction.

Authors:  Peichen Zhang; Liping Chen; Shengjie Wu; Bailiang Ye; Chao Chen; Lingyan Shi
Journal:  Pathol Oncol Res       Date:  2022-05-24       Impact factor: 2.874

3.  HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.

Authors:  Haineng Li; Jia Huang; Sa Yu; Hangbo Li; Yan Zhou; Qingwei Wu
Journal:  Oncol Lett       Date:  2021-04-26       Impact factor: 2.967

4.  TMPO-AS1 Regulates the Aggressiveness-Associated Traits of Nasopharyngeal Carcinoma Cells Through Sponging miR-320a.

Authors:  Biao Xing; Xiao-Feng Qiao; Yan-Hua Qiu; Xin Li
Journal:  Cancer Manag Res       Date:  2021-01-15       Impact factor: 3.989

5.  The Long Non-coding RNA TMPO-AS1 Promotes Bladder Cancer Growth and Progression via OTUB1-Induced E2F1 Deubiquitination.

Authors:  Yeyu Zhang; Yuxing Zhu; Mengqing Xiao; Yaxin Cheng; Dong He; Jianye Liu; Liang Xiang; Lian Gong; Zhanwang Wang; Liping Deng; Ke Cao
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

6.  A novel immune-related long non-coding RNAs risk model for prognosis assessment of lung adenocarcinoma.

Authors:  Songmei Lu; Nan Shan; Xingyue Chen; Fangliang Peng; Yiming Wang; Hao Long
Journal:  Aging (Albany NY)       Date:  2021-12-14       Impact factor: 5.682

7.  Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

Authors:  Przemysław A Stempor; Dror Avni; Raya Leibowitz; Yechezkel Sidi; Maria Stępień; Tomasz Dzieciątkowski; Paula Dobosz
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.